Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fraunhofer Center for Molecular Biotechnology
Newark, Delaware, United Statespmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
FhCMB has advanced multiple plant-derived vaccines into clinical trials, including a malaria transmission-blocking vaccine in Phase 2, an anthrax recombinant protective antigen vaccine in Phase 1, and influenza vaccines. Their platform enables rapid production of biotherapeutics and vaccines using plants. Early clinical results show safety and immunogenicity; further efficacy data pending.[7][8][3].
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineRecombinant proteinMonoclonal antibodyVirus-like particle vaccineProtein (fusion protein, recombinant antigens)
- Industry
- Academic Hospital/University/Research
02
Partnerships
PATH Malaria Vaccine Initiative/PATH Global Health Organization (malaria) [3],[7]iBio Inc. (technology commercialization/licensing partner) [4],[6],[2]Isconova AB (adjuvant partner for vaccines) [2]Accelovance/CRO partner for clinical trialsBioFactura/Geneva Foundation/USAMRIID/Ebola mAb program collaborator [5]Bend Research Inc. (thermostable formulation technology) [3]
Beyond the preview
Go deeper on Fraunhofer Center for Molecular Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fraunhofer Center for Molecular Biotechnology.